CompoAtlas

Zinc issu de feuille de goyave Bio

Food supplement declared in France, declaration No 2021-3-1023

Zinc issu de feuille de goyave Bio, from HAVEA COMMERCIAL SERVICES, is a food supplement declared in France. Status: withdrawal from the market announced for 16 July 2027. Main ingredients: Psidium guajava 250 mg per day, Fibres solubles d'acacia. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
HAVEA COMMERCIAL SERVICES
Status
Withdrawal from the market announced for 16 July 2027
Form
Capsule
Daily dose
1 gélule
Directions for use
à avaler avec un verre d'eau
Intended populations
Men, Women
Not recommended (according to the manufacturer)
Adolescents (under 18), Children (under 12), Young children (aged 1 to 3), Infants (under 1 year)
Objectives stated by the manufacturer (these are not authorised claims)
Antioxidant, Skin, Immunity

Declaration 223148, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Psidium guajava L.FeuilleExtrait sec hydroalcoolique250 mg

Other active ingredients

NamePer day
Fibres solubles d'acacianot declared

Other ingredients

Gélule végétale

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Zinc issu de feuille de goyave Bio: composition and regulation”, https://compoatlas.com/en/supplements/products/223148-zinc-issu-de-feuille-de-goyave-bio, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line